|
|
Drugs for Dependent Personality Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 68)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Paroxetine | approved, investigational | Phase 4 | 228 | 61869-08-7 | 43815 | (-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine (-)-Paroxetine (-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine (-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine (3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine (3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine 110429-35-1 3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride 61869-08-7 63952-24-9 64006-44-6 (maleate) 78246-49-8 (hydrochloride) AB00514724 AC1L2AKL AC1Q1H18 AC1Q4LV6 Aropax BIDD:GT0673 BPBio1_000949 BRD-K37991163-003-02-7 BRL 29060 BRL-29060 BSPBio_000861 C07415 C19H20FNO3 CHEBI:7936 CHEMBL490 CID43815 Casbol D02362 DB00715 DivK1c_006884 FG 7051 FG-7051 FT-0085087 Frosinor | HMS2090H05 I14-7752 KBio1_001828 KBio2_002232 KBio2_004800 KBio2_007368 KBioSS_002232 LS-114249 MolPort-003-849-791 Motivan NCGC00025355-02 NCGC00025355-03 NCGC00025355-04 NCGC00025355-05 NCGC00025355-06 NCGC00025355-07 NCGC00025355-08 NNC-20-7051 Paroxetina Paroxetina [INN-Spanish] Paroxetine Paroxetine (TN) Paroxetine (USP/INN) Paroxetine Hcl Paroxetine [USAN:INN:BAN] Paroxetinum Paroxetinum [INN-Latin] PaxPar Paxetil Paxil Paxil CR Pexeva Prestwick3_000851 Seroxat Seroxat CR SpecPlus_000788 Spectrum5_001665 Spectrum_001752 TL8003967 UNII-41VRH5220H [3H]Paroxetine paroxetine | |
| | 2 | | Sertraline | approved | Phase 4 | 299 | 79617-96-2 | 68617 | (+)-Sertraline (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (1S,4S)-sertraline (1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine (1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine (1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 79559-97-0 (Hydrochloride) 79617-96-2 AB00514002 AB1004870 AC-15639 AC1L2A41 AC1Q3O5N AC1Q3XJU Apo-Sertraline BIDD:GT0768 BIDD:PXR0193 BPBio1_001285 BRD-K82036761-003-02-1 BRN 5753709 BSPBio_001167 BSPBio_002698 C07246 C17H17Cl2N CHEBI:9123 CHEMBL809 CID68617 Cp 51974 D02360 DB01104 DB08567 FT-0081122 HSDB 7037 KBio3_001918 | KBioGR_001724 LS-94179 Lustral MLS001195647 MLS002222308 MolPort-002-885-860 NCGC00092386-03 NCGC00092386-04 NCGC00092386-05 NCGC00092386-06 NCGC00092386-07 NCGC00092386-08 NCGC00092386-09 Prestwick3_001014 SMR000596516 SPBio_000385 SRE Sertralina Sertralina [Spanish] Sertraline Sertraline (INN) Sertraline Hydrochloride Sertraline [INN:BAN] Sertraline [Zoloft] Sertraline hydrochloride Sertralinum Sertralinum [Latin] Spectrum2_000493 Spectrum3_001079 Spectrum4_001232 Sultamicillin Tosylate UNII-QUC7NX6WMB Zoloft cis-(+)-sertraline sertraline sertraline (Zoloft) |
| | 3 | | Fluoxetine | approved, vet_approved | Phase 4 | 238 | 54910-89-3 | 3386 | (+) or (-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine (+) or (-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine (+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine (+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine (+/-)-Fluoxetine (+/-)-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine (+/-)-N-Methyl-3-p-(p-trifluoromethylphenoxy)-3-phenylpropylamine (+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine (+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine] (+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine 3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine 52341-67-0 54910-89-3 57226-07-0 59333-67-4 (hydrochloride) AB00053774 AC-14564 AC1L1FTH AKOS003663021 Adofen Animex-On BPBio1_000354 BPBio1_000509 BRD-A31159102-001-01-9 BRD-A31159102-003-05-6 BSPBio_000461 BSPBio_003375 Bio-0787 Biomol-NT_000152 C17H18F3NO CHEBI:5118 CHEMBL41 CID3386 D00326 DB00472 Deprex DivK1c_006819 Eufor Floxetine Fluctin Fluoxeren Fluoxetin Fluoxetina Fluoxetina [INN-Spanish] Fluoxetina [Spanish] Fluoxetine (TN) Fluoxetine (USAN/INN) Fluoxetine Hcl Fluoxetine Hydrochloride Fluoxetine [USAN:INN:BAN] Fluoxetinum | Fluoxetinum [INN-Latin] Fluoxétine Fluval Fontex Foxetin HMS2090H14 KBio1_001763 KBio2_002159 KBio2_004727 KBio2_007295 KBio3_002595 KBioGR_001166 KBioSS_002159 L000931 LS-31040 Lilly-110140 Lopac0_000558 Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine MolPort-001-683-482 N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine NCGC00015428-10 NCGC00024879-03 NCGC00024879-04 NSC283480 Portal Prestwick0_000511 Prestwick1_000511 Prestwick2_000511 Prestwick3_000511 Prozac Prozac Weekly Pulvules Reconcile Reneuron SPBio_001815 SPBio_002382 STK734483 Sarafem SpecPlus_000723 Spectrum2_001658 Spectrum3_001648 Spectrum4_000613 Spectrum5_001518 Spectrum_001679 TL8003595 UNII-01K63SUP8D dl-3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine fluoxetine fluoxetine (Prozac) nchembio.534-comp2 |
| | 4 | | Citalopram | approved | Phase 4 | 512 | 59729-33-8 | 2771 | 1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile 1,3-dihydro[3,4]benzofuran-5-carbonitrile 1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile 59729-33-8 AB00513896 AC-12214 AC1L1EFH AE-641/00603021 Akarin BPBio1_000929 BRD-A47598013-004-02-0 BSPBio_000843 Bonitrile C07572 C20H21FN2O CHEBI:3723 CHEMBL549 CID2771 CPD000465669 Celapram Celexa Celius Ciazil Cilift Cipram Cipramil Ciprapine Citabax Citadur Citadur (TN) Citalec Citalopram (USP/INN) Citalopram Hydrobromide Citalopram [Celexa] Citalopram [INN:BAN] Citalopram hydrobromide Citalopramum Citalopramum [INN-Latin] | Citol Citopam Citox Citrol Cytalopram D07704 DB00215 Dalsan EINECS 261-891-1 Elopram HMS2090O09 HMS2093A14 Humorup I01-0382 InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3 L001223 LS-84327 Lopac0_000258 Lu 10-171 Lu-10-171 MolPort-003-666-794 NCGC00015267-07 NCGC00025160-02 Nitalapram Oropram Pramcit Prestwick3_000692 Recital SAM002589960 ST069372 STL058639 Seropram Talam Talohexal Temperax UNII-0DHU5B8D6V Vodelax Zentius Zetalo [3H]Citalopram citalopram | |
| | 5 | | Heroin | approved, illicit | Phase 4 | 115 | 561-27-3 | 5462328 | (5α,6α)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester) 3,6-Diacetylmorphine 7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate Diacetylmorphine | Diamorphine O,O'-Diacetylmorphine Smack diacetylmorphine diamorphine | |
| | 6 | | Naltrexone | approved, investigational, vet_approved | Phase 4 | 388 | 16590-41-3 | 5360515 | 16590-41-3 16676-29-2 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one 17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one 17-(Cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one 3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one BIDD:GT0405 BPBio1_000146 BRD-K88172511-310-03-8 BRN 3596648 BSPBio_000132 C07253 CCRIS 3506 CHEBI:121459 CHEBI:7465 CHEMBL142 CID5360515 Celupan D05113 DB00704 Depade EINECS 240-649-9 EN-1639A HMS2089O11 HS-0002 HSDB 6750 LS-92094 MLS002153483 MolPort-004-920-221 | MorViva N-Cyclopropylmethyl-14-hydroxydihydromorphinone N-Cyclopropylmethylnoroxymorphone Naltrexon Naltrexona Naltrexona [INN-Spanish] Naltrexone Naltrexone (USAN/INN) Naltrexone Hcl Naltrexone [USAN:BAN:INN] Naltrexone [USAN:INN:BAN] Naltrexone [Usan:Ban:Inn] Naltrexonum Naltrexonum [INN-Latin] PDSP2_000847 PTI-555 Prestwick0_000116 Prestwick1_000116 Prestwick2_000116 Prestwick3_000116 ReVia SMP1_000206 SPBio_002071 UM-792 UNII-5S6W795CQM Vivitrex Vivitrol Vivitrol (TN) naltrexone naltrexone (ReVia) | |
| | 7 | | Tranquilizing Agents | | Phase 4, Phase 1 | 4265 | | | | 8 | | Quetiapine Fumarate | | Phase 4 | 413 | 111974-72-2 | | | 9 | | Antipsychotic Agents | | Phase 4, Phase 1 | 2401 | | | | 10 | | Central Nervous System Depressants | | Phase 4, Phase 2, Phase 1 | 13403 | | | | 11 | | Psychotropic Drugs | | Phase 4, Phase 1 | 6430 | | | | 12 | | Narcotics | | Phase 4, Phase 3 | 3646 | | | | 13 | | Peripheral Nervous System Agents | | Phase 4, Phase 1 | 23689 | | | | 14 | | Narcotic Antagonists | | Phase 4 | 935 | | | | 15 | | Ethanol | approved | Phase 3, Phase 2 | 2137 | 64-17-5 | 702 | (C6-C9)Alkyl alcohol 02483_FLUKA 02851_FLUKA 02853_FLUKA 02854_FLUKA 02855_FLUKA 02856_FLUKA 02856_SIAL 02857_FLUKA 02857_SIAL 02858_FLUKA 02858_SIAL 02860_FLUKA 02865_FLUKA 02865_SIAL 02870_FLUKA 02870_SIAL 02875_FLUKA 02877_FLUKA 02878_FLUKA 02882_FLUKA 02882_SIAL 02883_FLUKA 02884_FLUKA 02890_FLUKA 02890_SIAL 02891_FLUKA 02891_SIAL 1-Hydroxyethane 100C.NPA 121182-78-3 187380_ALDRICH 187380_SIAL 24102_RIEDEL 24102_SIAL 24103_RIEDEL 24103_SIAL 24105_RIEDEL 24105_SIAL 24106_RIEDEL 24106_SIAL 24194_RIEDEL 24194_SIAL 245119_ALDRICH 245119_SIAL 270741_ALDRICH 270741_SIAL 277649_ALDRICH 277649_SIAL 2858_SIGMA 29221_FLUKA 32205_RIEDEL 32205_SIAL 32221_RIEDEL 32221_SIAL 32294_RIEDEL 32294_SIAL 34870_SIAL 34963_RIEDEL 39278_FLUKA 40210_ALDRICH 40210_RIEDEL 41322_FLUKA 458600_ALDRICH 458600_SIAL 459828_ALDRICH 459828_SIAL 459836_ALDRICH 459836_SIAL 459844_SIAL 48075_SUPELCO 493511_SIAL 493538_ALDRICH 493538_SIAL 493546_ALDRICH 493546_SIAL 64-17-5 676829_SIAL 68475-56-9 71076-86-3 71329-38-9 8000-16-6 8024-45-1 AC1L19TW AC1Q31MM AHD 2000 AI3-01706 ALCOHOL 5% IN D5-W Absolute Alcohol Absolute Ethanol Absolute alcohol Absolute ethanol Absolute ethyl alcohol Aethanol Aethanol [German] Aethylalkohol Alcare Hand Degermer Alcohol Alcohol (USP) Alcohol (ethyl) Alcohol Anhydrous Alcohol [USP] Alcohol anhydrous Alcohol dehydrated Alcohol denatured Alcohol etílico Alcohol, Absolute Alcohol, Dehydrated Alcohol, Diluted Alcohol, Grain Alcohol, anhydrous Alcohol, dehydrated Alcohol, denatured Alcohol, diluted Alcohol, ethyl Alcohols Alcohols, C1-3 Alcohols, C30 Alcohols, C6-9 Alcool Ethylique Alcool Etilico Alcool ethylique Alcool etilico Alcool éthylique Algrain Alkohol Alkohol [German] Alkoholu Etylowego Alkoholu etylowego Aminoethanol Anhydrol Anhydrol PM 4085 Anhydrous alcohol Anhydrous ethanol Beta-Aminoethanol Beta-Aminoethyl Alcohol Beta-Ethanolamine Beta-Hydroxyethylamine C00469 C2H5OH C2H6O CCRIS 945 CDA 19 CDA 19-200 CHEBI:16236 CHEMBL545 CID702 Caswell No. 426 Caswell No. 430 Colamine Cologne Spirit Cologne spirit Cologne spirits | D000431 D00068 DB00898 Dehydrated Ethanol Dehydrated alcohol Dehydrated ethanol Denatured Alcohol Denatured Alcohol Cd-10 Denatured Alcohol Cd-5 Denatured Alcohol Cd-5a Denatured Alcohol Sd-1 Denatured Alcohol Sd-13a Denatured Alcohol Sd-17 Denatured Alcohol Sd-23a Denatured Alcohol Sd-28 Denatured Alcohol Sd-30 Denatured Alcohol Sd-39b Denatured Alcohol Sd-39c Denatured Alcohol Sd-3a Denatured Alcohol Sd-40m Denatured Ethanol Denatured alcohol Denatured ethanol Desinfektol EL Diluted Alcohol Distilled spirits E2385_SIGMA E7023_ALDRICH E7023_SIAL E7148_ALDRICH E7148_SIAL E7517_SIGMA EINECS 200-578-6 EINECS 270-649-4 EOH EOX ETA Envision Conditioner Pdd 9020 Esumiru WK 88 EtOH Etanolo Etanolo [Italian] Ethanol (9CI) Ethanol 200 Proof Ethanol 200 proof Ethanol Absolute Ethanol Absolute Bp Ethanol Anhydrous Ethanol Extra Pure Ethanol Vapor Ethanol [JAN] Ethanol solution Ethanol, Silent Spirit Ethanol, undenatured Ethanolum anhydricum Ethicap Ethyl Alcohol Ethyl Alcohol & Water, 10% Ethyl Alcohol & Water, 20% Ethyl Alcohol & Water, 30% Ethyl Alcohol & Water, 40% Ethyl Alcohol & Water, 5% Ethyl Alcohol & Water, 50% Ethyl Alcohol & Water, 60% Ethyl Alcohol & Water, 70% Ethyl Alcohol & Water, 80% Ethyl Alcohol & Water, 95% Ethyl Alcohol & Water, 96% Ethyl Alcohol Anhydrous Ethyl Alcohol, Anhydrous Ethyl Alcohol, Denatured Ethyl Hydrate Ethyl Hydroxide Ethyl alc Ethyl alcohol Ethyl alcohol anhydrous Ethyl alcohol in alcoholic beverages Ethyl alcohol usp Ethyl hydrate Ethyl hydroxide Ethylalcohol Ethylalcohol [Dutch] Ethylol Ethylolamine Ethyloxy Group Etylowy alkohol FEMA No. 2419 FEMA Number 2419 Fermentation alcohol Glycinol Grain alcohol HSDB 531 HSDB 82 HYDROXYETHYL GROUP Hinetoless Hydroxyethane I14-12648 IMS 99 Infinity Pure Jaysol Jaysol S LS-1539 LTBB002977 Lux Methylated Spirit Mineralised Methylated spirit Methylcarbinol MolPort-001-785-844 Molasses alcohol NCGC00091458-01 NCI-C03134 NSC 85228 NSC85228 Oxydimethylene Group Potato alcohol Punctilious ethyl alcohol Pyro QMHAIh@ Reagent Alcohol Ru-Tuss Expectorant SDA 3A SDA 40-2 SDM No. 37 SY Fresh M Sekundasprit Silent spirit Spirit Spirits of wine Spiritus vini Spirt Synasol Tecsol Tecsol C Thanol Thiofaco M-50 UNII-3K9958V90M USAF EK-1597 Undenatured Ethanol WLN: Q2 absolute alcohol alcohol alcohol etilico bmse000297 etanol ethanol ethyl alcohol grain alcohol nchem.651-comp3c nchembio.552-comp10 nchembio.94-comp20 spiritus vini Äthanol Äthylalkohol éthanol | |
| | 16 | | Acamprosate | approved, investigational | Phase 2 | 39 | 77337-76-9 | 71158 | 3-(Acetylamino)propanesulphonic acid 3-Acetamido-1-propanesulfonic acid 3-acetamidopropane-1-sulfonic acid 77337-70-3 (mono-hydrochloride salt) 77337-71-4 (mono-potassium salt) 77337-72-5 (mono-lithium salt) 77337-73-6 (calcium[2:1] salt) 77337-74-7 (magnesium[2:1] salt) 77337-76-9 AC1L2FNA AC1Q1L6O AC1Q6X8K AOTA AR-1H6082 Acamprosate Acamprosate (INN) Acamprosate 6473 Acamprosate [INN:BAN] Acamprosato Acamprosato [INN-Spanish] Acamprosatum | Acamprosatum [INN-Latin] Aotal Aotal (TN) C5H11NO4S CHEBI:51041 CID71158 Campral D07058 DB00659 EINECS 278-667-4 HSDB 7358 LS-120940 N-Acetylhomotaurine N-acetyl homotaurine UNII-N4K14YGM3J acamprosate acamprosate (Campral) acamprostate calcium acetyl homotaurinate calcium acetylhomotaurinate calcium acetylhomotaurine sodium acetylhomotaurine | |
| | 17 | | Acetylcysteine | approved, investigational | Phase 2 | 330 | 616-91-1 | 12035 | (2R)-2-acetylamino-3-sulfanylpropanoic acid (R)-2-acetylamino-3-mercaptopropanoic acid (R)-mercapturic acid 2-Acetylamino-3-mercapto-propionate 2-Acetylamino-3-mercapto-propionic acid ACC Acetadote Acetilcisteina Acetylcysteine Acetylcysteinum Fluimicil Infantil Fluimucetin Fluimucil Flumucetin Fluprowit | L-Acetylcysteine L-acetylcysteine L-α-acetamido-β-mercaptopropionic acid Lysox Mercapturic acid Mucolysin Mucomyst N-Acety-L-Cysteine N-Acetyl-3-mercaptoalanine N-Acetyl-L-(+)-cysteine N-Acetylcysteine N-acetyl-L-(+)-cysteine N-acetyl-L-cysteine N-acetylcysteine NAC Parvolex Sodium 2-acetamido-3-mercaptopropionate |
| | 18 | | Protective Agents | | Phase 2, Phase 1 | 7443 | | | | 19 | | Antioxidants | | Phase 2, Phase 1 | 3050 | | | | 20 | | Anti-Infective Agents, Local | | Phase 2 | 1880 | | | | 21 | | Anti-Infective Agents | | Phase 2 | 22062 | | | | 22 | | Respiratory System Agents | | Phase 2 | 4997 | | | | 23 | | N-monoacetylcystine | | Phase 2 | 330 | | | | 24 | | Expectorants | | Phase 2 | 404 | | | | 25 | | Antiviral Agents | | Phase 2 | 9967 | | | | 26 | | Antidotes | | Phase 2 | 1071 | | | | 27 | | glutamine | Nutraceutical | Phase 2 | 162 | | | | 28 | | Glutamic Acid | Nutraceutical | Phase 2 | 228 | | | | 29 | | Pramipexole | approved, investigational | Phase 1 | 139 | 104632-26-0 | 59868, 119570 | (-)-Pramipexole (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine (6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine (6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole (S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine 104632-26-0 111GE001 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole 2-amino-6-propylaminotetrahydrobenzothiazole AC1L3P1T BIDD:GT0250 C10H17N3S CHEBI:8356 CHEMBL301265 CID119570 CPD000449298 D05575 DivK1c_006916 Furfuryl Acetate HMS2051A21 HMS2090C15 KBio1_001860 KBio2_002340 KBio2_004908 | KBio2_007476 KBioSS_002343 LS-40722 MLS000758250 MLS001423952 Mirapex MolPort-003-849-957 NCGC00167441-01 Pramipexol Pramipexol [Spanish] Pramipexole Pramipexole (USAN/INN) Pramipexole 2HCl Monohydrate Pramipexole [USAN:INN] Pramipexole hydrochloride Pramipexolum Pramipexolum [Latin] SAM001247006 SBB070477 SMR000449298 SND-919 SUD919CL2Y SpecPlus_000820 Spectrum5_001453 Spectrum_001838 U-98528E pramipexole |
| | 30 | | Sulpiride | approved | Phase 1 | 44 | 15676-16-1 | 5355 | ( inverted question mark)-Sulpiride (+-)-Sulpiride (+/-)-Sulpiride (?)-Sulpiride (RS)-(+/-)-sulpiride 15676-16-1 23672-07-3 5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide 5-22-08-00105 (Beilstein Handbook Reference) AC-12181 AC1L1K62 AKOS004912732 Abilit Aiglonyl Alimoral Allphar Brand of Sulpiride Almirall Brand of Sulpiride Areu Brand of Sulpiride Arminol BPBio1_000233 BPBio1_000463 BPBio1_001255 BRD-A55272860-001-03-9 BRD-A55272860-001-04-7 BRN 0494008 BSPBio_000211 Bio-0717 Biomol-NT_000037 Biomol-NT_000162 C15H23N3O4S CCRIS 4248 CHEMBL26 CID5355 Calmoflorine Centrum Brand of Sulpiride Championyl Coolspan D01226 D013469 DB00391 Darleton Deponerton Desisulpid Desitin Brand of Sulpiride Desmenat Digton DivK1c_000278 Dobren Dogmatil Dogmatyl Dogmatyl (TN) Dolmatil Dolorgiet Brand of Sulpiride Dresent EINECS 239-753-7 EU-0001755 EU-0101050 Eglonil Eglonyl Ekilid Enimon Equilid Erempharma Brand of Sulpiride Eusulpid Fardalan Fidelan Fumouzer Brand of Sulpiride Guastil HMS1568K13 HMS500N20 Hennig Brand of Sulpiride Hexal Brand of Sulpiride Hoechst Brand of Sulpiride Hormosan Brand of Sulpiride I06-0054 IDI1_000278 Isnamide KBio1_000278 Krewel Brand of Sulpiride Kylistro L000579 LS-20058 LS-20059 Lebopride Levobren Levopraid Levosulpirida Levosulpirida [INN-Spanish] | Levosulpiride Levosulpiride [INN] Levosulpiridum Levosulpiridum [INN-Latin] Lisopiride Lopac0_001050 MLS000069434 MLS001306443 Magnetic resonance imaging sulpiride Mariastel Meresa Miradol Mirbanil Misulvan MolPort-002-070-475 N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide NCGC00015966-04 NCGC00015966-08 NCGC00024852-02 NCGC00024852-03 NCGC00024852-04 NCGC00024852-05 NINDS_000278 Neogama Norestran Normum Nufarol Omiryl Omperan Oprea1_602476 Ozoderpin Pharmacia Brand of Sulpiride Pontiride Prestwick0_000056 Prestwick1_000056 Prestwick2_000056 Prestwick3_000056 Prestwick_431 Psicocen Psicofarma Brand of Sulpiride Pyrikappl Pyrkappl R. D. 1403 R.D. 1403 RD 1403 RV-12309 Restful Rosemont Brand of Sulpiride S 8010 S-(-)-Sulpiride S8010_SIGMA SMR000038923 SPBio_002132 STK368596 Sanofi Synthelabo Brand of Sulpiride Sanofi-Synthelabo Brand of Sulpiride Sernevin Splotin Spyfarma Brand of Sulpiride Stamonevrol Sulp Sulperide Sulpirid Sulpirida Sulpirida [INN-Spanish] Sulpiride (JP15/USAN/INN) Sulpiride [USAN:INN:BAN:JAN] Sulpiridum Sulpiridum [INN-Latin] Sulpitil Sulpivert Sulpor Sulpride Sulpyrid Suprium Sursumid Synedil Tepavil Uriach Brand of Sulpiride Valirem Vertigo Meresa Vertigo-Meresa Zemorcon nchembio873-comp17 sulpiride vertigo neogama vertigo-neogama | |
| | 31 | | Dopamine | approved | Phase 1 | 3836 | 51-61-6, 62-31-7 | 681 | (3H)-Dopamine .Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride .alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI) 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium 153C5321-5FEE-4B0B-8925-F388F0EEEBD1 2-(3,4-Dihydroxyphenyl)ethylamine 2-(3,4-dihydroxyphenyl)ethylamine 2-benzenediol 3,4-Dihydroxyphenethylamine 3,4-Dihydroxyphenethylamine hydrochloride 3,4-Dihydroxyphenylethylamine 3,4-dihydroxyphenethylamine 3-Hydroxtyramine 3-Hydroxytyramine 3-Hydroxytyramine Hydrobromide 3-Hydroxytyramine hydrochloride 4-(2-Aminoethyl)-1, 4-(2-Aminoethyl)-1,2-benzenediol 4-(2-Aminoethyl)-1,2-bezenediol 4-(2-Aminoethyl)-Pyrocatechol 4-(2-Aminoethyl)benzene-1,2-diol 4-(2-Aminoethyl)catechol 4-(2-Aminoethyl)pyrocatechol 4-(2-Aminoethyl)pyrocatechol hydrochloride 4-(2-aminoethyl)-pyrocatechol 50444-17-2 51-61-6 62-31-7 (HYDROCHLORIDE) AC1L19S5 AC1Q54AX AC1Q54AY AKOS003790978 ASL 279 BIDD:ER0506 BPBio1_001123 BSPBio_001932 Biomol-NT_000001 C03758 CHEBI:18243 CHEMBL59 CID681 D07870 DB00988 Deoxyepinephrine DivK1c_000780 Dopamin Dopamina Dopamina [INN-Spanish] Dopamine Dopamine (INN) Dopamine (USAN)(*hydrochloride*) Dopamine [INN:BAN] Dopaminum Dopaminum [INN-Latin] Dopastat Dophamine Dynatra EINECS 200-110-0 HSDB 3068 Hydroxytyramin Hydroxytyramine IDI1_000780 IP 498 Intropin Intropin [*hydrochloride*] KBio1_000780 | KBio2_001492 KBio2_002388 KBio2_002484 KBio2_004060 KBio2_004956 KBio2_005052 KBio2_006628 KBio2_007524 KBio2_007620 KBio3_001152 KBio3_002867 KBio3_002962 KBioGR_001129 KBioGR_002388 KBioGR_002484 KBioSS_001492 KBioSS_002393 KBioSS_002491 KW-3-060 L-DOPAMINE L000232 LDP LS-159 Lopac-H-8502 Lopac0_000586 Medopa (TN) MolPort-001-641-000 NCGC00015519-01 NCGC00015519-08 NCGC00096050-01 NCGC00096050-02 NCGC00096050-03 NCGC00096050-04 NCGC00096050-05 NINDS_000780 NSC 173182 NSC169105 NSC173182 Oprea1_088821 Oxytyramine Pyrocatechol, 4-(2-aminoethyl)- (8CI) Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride Revimine Revivan SPBio_001205 SPECTRUM1505155 ST048774 STK301601 Spectrum2_001023 Spectrum3_000406 Spectrum4_000525 Spectrum5_000945 Spectrum_001012 UNII-VTD58H1Z2X UPCMLD0ENAT5885989:001 a-(3,4-Dihydroxyphenyl)-b-aminoethane alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane cMAP_000036 cMAP_000065 dopamine hydroxytyramine intropin m-Hydroxytyramine hydrochloride nchembio.105-comp9 nchembio.107-comp4 nchembio.284-comp1 nchembio.78-comp16 nchembio.89-comp3 nchembio705-8 nchembio801-comp8 |
| | 32 | | Prednisone | approved, vet_approved | Phase 1 | 1398 | 53-03-2 | 5865 | (1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione .delta. E .delta.(sup1)-Cortisone .delta.-Cortelan .delta.-Cortisone .delta.-Cortone .delta.-E .delta.1-Cortisone .delta.1-Dehydrocortisone .delta.sone 1,2-Dehydrocortisone 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione 1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione 1-Cortisone 1-Dehydrocortisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione 17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione 53-03-2 68-59-7 81552_FLUKA AC-11112 AC1L1LB2 AC1Q29EZ ACon0_000082 ACon1_000297 AI3-52939 Adasone Ancortone Apo-Prednisone Apo-prednisone BPBio1_000323 BRD-K85883481-001-04-2 BSPBio_000293 Betapar Bicortone Bio-0649 C07370 C21H26O5 CCRIS 2646 CHEBI:8382 CHEMBL635 CID5865 CPD001227202 Cartancyl Colisone Cortan Cortancyl Cortidelt Cotone DB00635 Dacorten Dacortin Decortancyl Decortin Decortisyl Dehydrocortisone Dekortin Delcortin Dellacort Dellacort A Delta Cortelan Delta E Delta E. Delta-Cortelan Delta-Dome Delta-cortelan Delta-cortisone Delta-cortone Delta-dome Deltacortene Deltacortisone Deltacortone Deltasone Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone Deltison Deltisona Deltisone Deltra Di-Adreson Diadreson EINECS 200-160-3 Econosone Encorton Encortone Enkortolon Enkorton Fernisone Fiasone HMS1568O15 HMS2090J13 HSDB 3168 Hostacortin In-Sone Incocortyl | Juvason Kortancyl LMST02030180 LS-1325 Liquid Pred Lisacort Lodotra MEGxm0_000443 MLS001061265 MLS001304073 MLS001335907 MLS001335908 MLS002154191 MLS002207083 Me-Korti Metacortandracin Meticorten Meticorten (Veterinary) Metrevet (Veterinary) MolPort-001-740-041 NCGC00090766-01 NCGC00090766-02 NCGC00090766-03 NCI-C04897 NCI60_000008 NSC 10023 NSC10023 Nisona Nizon Novoprednisone Nurison Orasone Origen Prednisone P1276 P6254_SIGMA PRD Panafcort Panasol Paracort Parmenison Pehacort Precort Predeltin Prednicen-M Prednicorm Prednicort Prednicot Prednidib Prednilonga Prednison Prednisona Prednisona [INN-Spanish] Prednisone Prednisone Intensol Prednisone [INN:BAN] Prednisonum Prednisonum [INN-Latin] Prednitone Prednizon Prednovister Presone Prestwick0_000077 Prestwick1_000077 Prestwick2_000077 Prestwick3_000077 Prestwick_405 Pronison Pronisone Rectodelt Retrocortine S1622_Selleck SAM002264641 SK-Prednisone SMR000718760 SMR001227202 SPBio_002214 Servisone Sone Sterapred Supercortil U 6020 UNII-VB0R961HZT Ultracorten Ultracortene WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ Winpred Wojtab ZINC03875357 Zenadrid Zenadrid (veterinary) Zenadrid [veterinary] delta cortelan delta(sup 1)-Cortisone delta(sup 1)-Dehydrocortisone delta-1-Cortisone delta-1-Dehydrocortisone delta-Cortisone delta-Cortone | |
| | 33 | | Dexamethasone | approved, investigational, vet_approved | Phase 1 | 2171 | 50-02-2 | 5743 | (3H)-Dexamethasone .delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol .gamma.corten 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone 1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone 1-Dehydro-16α-methyl-9α-fluorohydrocortisone 137098-19-2 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone 16-alpha-Methyl-9-alpha-fluoroprednisolone 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol 16alpha -Methyl-9alpha -fluoroprednisolone 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone 16alpha-Methyl-9alpha-fluoroprednisolone 16α-Methyl-9α-fluoro-1-dehydrocortisol 23495-06-9 31375_FLUKA 46165_FLUKA 46165_RIEDEL 50-02-2 8054-59-9 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione 9-Fluoro-16-methylprednisolone 9-alpha-Fluoro-16-alpha-methylprednisolone 9.alpha.-Fluoro-16.alpha.-methylprednisolone 906422-84-2 9A-FLUORO-16BETA-METHYLPREDNISOLONE 9alpha -Fluoro-16alpha -methylprednisolone 9alpha-Fluoro-16alpha-methylprednisolone 9alpha-fluoro-16alpha-methyl-Prednisolone 9α-Fluoro-16α-methylprednisolone AC-11056 AC1L1L1H AC1Q29DM AI3-50934 Adexone Aeroseb-D Aeroseb-Dex Aeroseb-dex Ak Dex Oph Otic Soln 0.1% Alcon Brand of Dexamethasone Anaflogistico Aphtasolon Aphthasolone Apo-dexamethasone Auxiron Azimycin (veterinary) Azium Azium (Veterinary) Azium (veterinary) BIDD:ER0494 BIDD:PXR0060 BRD-K38775274-001-02-3 BRD-K38775274-001-06-4 BSPBio_000995 Bisu DS Bisu Ds C15643 C22H29FO5 CCRIS 7067 CHEBI:41879 CHEMBL384467 CID5743 CPD-10549 CPD001227192 Calonat Corson Corsone Cortisumman D00292 D003907 D1756_SIGMA D4902_SIGMA D6645_SIGMA D8893_SIGMA D9184_SIGMA DB01234 DEX DEXA DEXONE 0.5 DEXONE 0.75 DEXONE 1.5 DEXONE 4 DXM DXMS Decacort Decacortin Decaderm Decadron Decadron (TN) Decadron Tablets, Elixir Decadron, Dexamethasone Decadron-LA Decadron-La Decagel Decaject Decaject L.A. Decaject-L.A. Decalix Decameth Decasone Decaspray Dectancyl Dekacort Delta1-9alpha-Fluoro-16alpha-methylcortisol Deltafluorene Dergramin Deronil Desadrene Desametasone Desametasone [DCIT] Desametasone [Dcit] Desamethasone Desameton Deseronil Dex-Ide Dex-ide Dexa Dexa Mamallet Dexa mamallet Dexa-Cortidelt Dexa-Cortisyl Dexa-Mamallet Dexa-Scheroson Dexa-Sine Dexa-cortidelt Dexa-cortisyl Dexa-scheroson Dexa-sine Dexacen-4 Dexacidin Dexacort Dexacortal Dexacortin Dexadeltone Dexafarma Dexair Dexalona Dexaltin Dexametasona Dexametasona [INN-Spanish] Dexametasone | Dexameth Dexamethansone Dexamethasone Dexamethasone (JP15/USP/INN) Dexamethasone Acetate Dexamethasone Alcohol Dexamethasone Base Dexamethasone Intensol Dexamethasone Sodium Phosphate Dexamethasone [INN:BAN:JAN] Dexamethasone alcohol Dexamethasone base Dexamethasone intensol Dexamethasone-omega Dexamethasonum Dexamethasonum [INN-Latin] Dexamethazone Dexamonozon Dexapolcort Dexapos Dexaprol Dexason Dexasone Dexasone 0.5mg Dexasone 0.75mg Dexasone 4mg Dexasporin Dexinolon Dexinoral Dexone Dexone 0.5 Dexone 0.75 Dexone 1.5 Dexone 4 Dexonium Dexpak Dextelan Dezone Dinormon Dxms ECR Brand of Dexamethasone EINECS 200-003-9 FT-0080377 Fluormethylprednisolone Fluormone Fluorocort Fortecortin Foy Brand of Dexamethasone Gammacorten HL-dex HMS1792A17 HMS1990A17 HMS2089N13 HSDB 3053 Hexadecadrol Hexadrol Hexadrol Elixir Hexadrol Tablets Hexadrol elixir Hl-Dex Hl-dex I06-1196 ICN Brand of Dexamethasone IontoDex Isopto-Dex Isopto-dex LS-7300 Lokalison F Lokalison f Loverine Luxazone MK 125 MLS001055412 MLS001332507 MLS001332508 Maxidex Maxidex Ont 0.1% Maxidex Sus 0.1% Maxitrol Mediamethasone Merck Brand of Dexamethasone Merz Brand 1 of Dexamethasone Merz Brand 2 of Dexamethasone Methylfluorprednisolone Mexidex Millicorten MolMap_000018 MolPort-003-846-433 Mymethasone NCGC00091019-01 NCGC00091019-02 NCGC00091019-03 NCGC00091019-04 NCGC00091019-05 NCI60_003067 NSC 34521 NSC34521 Naquasone (veterinary) Neomycin and polymyxin b sulfates and dexamethasone Neomycin and polymyxin b sulphates and dexamethasone OTO-104 Ocu-Trol Ocu-trol Oradexon PHL-dexamethasone PMS-dexamethasone Pet Derm III Pet Derm Iii Pet derm III Pet-Derm Iii Pms Dexamethasone Elixir 0.5mg/5ml Policort Posurdex Prednisolon F Prednisolon f Prednisolone F Prednisolone f Prodex S1322_Selleck SAM002548948 SGCUT00126 SK-Dexamethasone SK-dexamethasone SMP1_000092 SMR000857119 SMR001227192 ST50307091 Sandoz dexamethasone Sk-Dexamethasone Spectrum5_002019 Spoloven Sunia Sol D Sunia sol D Superprednol TL8003317 Tobradex Tobramycin and dexamethasone Tresaderm (veterinary) Turbinaire UNII-7S5I7G3JQL Visumetazone WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1 ZINC03875332 alpha -Fluoro-16-alpha -methylcortisol delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta1-9alpha-Fluoro-16alpha-methylcortisol dexamethasone nchembio809-comp2 to_000038 |
| | 34 | | Docetaxel | approved, investigational, Approved May 1996 | Phase 1 | 1967 | 114977-28-5 | 148124, 9877265 | (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxybenzenepropanoate (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate 01885_FLUKA 114977-28-5 4-(Acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate AC-383 AC1L3WHJ ANX-514 BIND-014 C11231 CHEBI:4672 CHEMBL92 CID148124 D07866 DB01248 Docetaxel Docetaxel (INN) Docetaxel anhydrous Docetaxel, Trihydrate EmDOC | HMS2089K08 InChI=1/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,5 MolPort-003-847-005 N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol N-debenzoyl-N-Boc-10-deacetyl taxol NSC-628503 PSMA-targeted docetaxel nanoparticle RP-56976 SDP-014 TXL Taxotere Taxotere (TN) Taxotere(R) XRP-6976L docetaxel docetaxel 114977-28-5 nchembio.188-comp8 nchembio.2007.34-comp7 nchembio.573-comp11 nchembio853-comp8 |
| | 35 | | sultopride | | Phase 1 | 48 | | | | 36 | | Dopamine Agents | | Phase 1 | 3836 | | | | 37 | | Central Nervous System Stimulants | | Phase 1 | 2211 | | | | 38 | | Autonomic Agents | | Phase 1 | 10150 | | | | 39 | | Antiparkinson Agents | | Phase 1 | 1574 | | | | 40 | | Antidepressive Agents | | Phase 1 | 2736 | | | | 41 | | Dopamine agonists | | Phase 1 | 632 | | | | 42 | | Antidepressive Agents, Second-Generation | | Phase 1 | 1311 | | | | 43 | | Dopamine Antagonists | | Phase 1 | 1093 | | | | 44 | | Neurotransmitter Agents | | Phase 1 | 18340 | | | | 45 | | HIV Protease Inhibitors | | Phase 1 | 5470 | | | | 46 | | glucocorticoids | | Phase 1 | 5103 | | | | 47 | | protease inhibitors | | Phase 1 | 5471 | | | | | 48 | | Hormones, Hormone Substitutes, and Hormone Antagonists | | Phase 1 | 13168 | | | | 49 | | Hormones | | Phase 1 | 14415 | | | | 50 | | Hormone Antagonists | | Phase 1 | 13180 | | |
Interventional clinical trials: (show all 19)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope | Unknown status | NCT01357967 | Phase 4 | | 2 | Biomarkers of Injectable Extended Release Naltrexone Treatment | Enrolling by invitation | NCT02324725 | Phase 4 | | 3 | Making Alcoholics Anonymous Easier | Completed | NCT01382316 | Phase 3 | | 4 | Acamprosate to Reduce Symptoms of Alcohol Withdrawal | Completed | NCT00106106 | Phase 2 | | 5 | N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD | Terminated | NCT00539188 | Phase 2 | | 6 | Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors | Completed | NCT00471588 | Phase 1 | | 7 | Reducing Dexamethasone Around Docetaxel Infusion | Recruiting | NCT02776436 | Phase 1 | | 8 | Differential Efficacy of Supportive and Interpretative Psychodynamic Techniques for Dependent and Self-critical Depressive Patients | Unknown status | NCT01640483 | | | 9 | Epidemiological Studies of Eating Disorders in Gifted Dance Students (2nd Year). | Completed | NCT00173160 | | | 10 | Reward Processing in Cocaine Addiction | Completed | NCT01036074 | | | 11 | Narrative Exposure Therapy in Women With Borderline Personality Disorder and Posttraumatic Stress Disorder | Recruiting | NCT02517723 | | | 12 | Training of Neural Responding in BPD | Recruiting | NCT02866110 | | | 13 | Personality Pathology and Cerebral Processing in Eating Disorders | Recruiting | NCT02980120 | | | 14 | Characterization Imaging Instruments in Alcoholics and Non-Alcoholics | Recruiting | NCT02108080 | | | 15 | Endogenous Opioid Mechanisms for Rejection Sensitivity | Recruiting | NCT02189785 | | | 16 | Vulnerability Markers in Pathological Gambling | Recruiting | NCT02873572 | | | 17 | Risk Factors Associated With Binge Drinking Behaviors Among College Students | Recruiting | NCT02794311 | | | 18 | Inhibitory Control of the Mind : Neural Bases and Impact for Obsessive-compulsive Disorders | Not yet recruiting | NCT02850393 | | | 19 | Assessment of Persistent Cognitive Impairment After Cure of Cushing's Disease | Not yet recruiting | NCT02603653 | |
|
